Evidence map›Paper›PMID 38890228›Full record

Trial reportJournal of cachexia, sarcopenia and muscle2024

Beneficial effects of exercise, testosterone, vitamin D, calcium and protein in older men-A randomized clinical trial.

Mette Midttun, Karsten Overgaard, Bo Zerahn, Maria Pedersen, Anahita Rashid, Peter Busch Østergren, Tine Kolenda Paulin, Thea Winther Pødenphanth, Linda Katharina Karlsson, Eva Rosendahl and 3 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of cachexia, sarcopenia and muscle, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mette MidttunMedical Department O, University Hospital of Copenhagen, Herlev Hospital, Herlev, Denmark.
Karsten OvergaardNeurological Department N, University Hospital of Copenhagen, Herlev Hospital, Herlev, Denmark.
Bo ZerahnDepartment of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Herlev Hospital, Herlev, Denmark.
Maria PedersenDepartment of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Herlev Hospital, Herlev, Denmark.
Anahita RashidDepartment of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Herlev Hospital, Herlev, Denmark.
Peter Busch ØstergrenDepartment of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.
Tine Kolenda PaulinMedical Department O, University Hospital of Copenhagen, Herlev Hospital, Herlev, Denmark.
Thea Winther PødenphanthMedical Department O, University Hospital of Copenhagen, Herlev Hospital, Herlev, Denmark.
Linda Katharina KarlssonMedical Department O, University Hospital of Copenhagen, Herlev Hospital, Herlev, Denmark.
Eva RosendahlMedical Department O, University Hospital of Copenhagen, Herlev Hospital, Herlev, Denmark.
Anne-Mette RagleDepartment of Physiotherapy and Occupational Therapy, University Hospital of Copenhagen, Herlev Hospital, Herlev, Denmark.
Anders VintherDepartment of Physiotherapy and Occupational Therapy, University Hospital of Copenhagen, Herlev Hospital, Herlev, Denmark.
Rune Skovgaard RasmussenNeurological Department N, University Hospital of Copenhagen, Herlev Hospital, Herlev, Denmark.ORCID 0000-0002-5630-122X

Funding

Aase og Ejnar Danielsens FondAny and Richard Sperling's FoundationBeckett FoundationFoundation JuchumHelsefondenMarie and Børge Krogh's FoundationVelux Foundation
6 · The paper itself

Abstract

backgroundDue to increasing older populations worldwide, injuries, disabilities and deaths caused by falls among the elderly represent a growing human and societal problem. We aimed to improve health among men of at least 70 years of age with low-normal to low testosterone and mobility problems by using testosterone undecanoate (TU) injections, progressive strength training, and oral supplements of vitamin D, calcium and protein.

methodsThis was a single-centre, randomized, placebo-controlled, double-blind trial with 148 older men with a median age of 77 (73-81) years, testosterone levels at median 8 (5-9) nmol/L (full range from 1.1 to 12.9 nmol/L) and mobility problems, recruited at University Hospital of Copenhagen, Herlev Hospital, Denmark. Participants were randomized into four arms for 20 weeks: (1) TU therapy (n = 37); (2) progressive resistance training with supplements of calcium, vitamin D and protein (n = 36); (3) both interventions combined (n = 36); or (4) no intervention (n = 39). The main outcome measure was the 30-s chair stand test, due to test performance correlating with the risk of serious fall injuries and lower extremity muscle strength. Outcome measurements were performed at baseline and after 20 weeks.

resultsAfter the intervention, the combination group receiving progressive resistance training, TU and supplements achieved a median score of 13 (11-15) compared to the control group at 10 (0-14) in the 30-s chair stand test (P = 0.003). This median improvement of 3.0 was clinically important. Compared to the control group, participants in the combination group also increased quality of life (P < 0.05) and reduced both tiredness (P < 0.05) and leg fat (P < 0.05) and had higher variability in the RR interval (P < 0.01). The group receiving TU reduced gynoid and leg fat compared to the control group (both P < 0.05). Blood tests improved for several variables, especially in the combination group. There was no statistically significant increase in adverse effects from either the supplements or training.

conclusionsIn men ≥70 years old with low-normal to low testosterone and mobility problems, supplements of testosterone, calcium, vitamin D and protein combined with progressive resistance training improved 30-s chair stand test performance, muscle strength and quality of life. Both tiredness and leg fat were reduced, and RR interval variability was increased. Significant adverse effects were not observed.

Indexed as

CalciumExerciseTestosteroneVitamin DAgedAged, 80 and overDietary ProteinsDietary SupplementsDouble-Blind MethodHumansMaleMuscle StrengthResistance TrainingCalciumDietary ProteinsTestosteroneVitamin Delderlyfallsphysical exercisetestosterone therapy

Identifiers

PMID38890228
PMCPMC11294024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.